MimiX (Biotechnology) Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
MimiX (Biotechnology) General Information
Description
Developer of a biofabrication technology intended to enable tissue manufacturing for therapeutic and diagnostic purposes. The company offers a cost-efficient tissue engineering approach to regenerative, patient-tailored precision medicine, enabling medical practitioners with an ultra-fast biomanufacturing technology capable of creating point-of-care patient-specific biological tissue equivalents for regenerative, personalized, and precision medicine.
Contact Information
Website
www.mimixbio.comCorporate Office
- Care of Switzerland Innovation Park
- Aarbergstrasse 46
- 2503 Biel
- Switzerland
Corporate Office
- Care of Switzerland Innovation Park
- Aarbergstrasse 46
- 2503 Biel
- Switzerland
MimiX (Biotechnology) Timeline
MimiX (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 01-May-2026 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 16-Oct-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 21-Dec-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 19-Aug-2020 | $43.7K | $43.7K | Completed | Generating Revenue | |
| 1. Grant | 31-Mar-2020 | $10.4K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MimiX (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MimiX (Biotechnology) Patents
MimiX (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023161769-A1 | Method for producing tissue constructs | Inactive | 22-Feb-2022 |
MimiX (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MimiX (Biotechnology) Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Prevail Private Capital | Venture Capital | Minority | ||
| Asia Jetway | Corporation | Minority | ||
| AO Foundation | Government | Minority | ||
| Heraeus Holding | Corporation | Minority | ||
| Venture Kick | Accelerator/Incubator | Minority |
MimiX (Biotechnology) FAQs
-
When was MimiX (Biotechnology) founded?
MimiX (Biotechnology) was founded in 2019.
-
Where is MimiX (Biotechnology) headquartered?
MimiX (Biotechnology) is headquartered in Biel, Switzerland.
-
What is the size of MimiX (Biotechnology)?
MimiX (Biotechnology) has 6 total employees.
-
What industry is MimiX (Biotechnology) in?
MimiX (Biotechnology)’s primary industry is Biotechnology.
-
Is MimiX (Biotechnology) a private or public company?
MimiX (Biotechnology) is a Private company.
-
What is MimiX (Biotechnology)’s current revenue?
The current revenue for MimiX (Biotechnology) is .
-
How much funding has MimiX (Biotechnology) raised over time?
MimiX (Biotechnology) has raised $7.39M.
-
Who are MimiX (Biotechnology)’s investors?
Prevail Private Capital, Asia Jetway, AO Foundation, Heraeus Holding, and Venture Kick have invested in MimiX (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
